Article

Would you date a cancer survivor?

Author(s):

Dating and finding the one and only person meant for you--your soul mate--isn't an easy feat for anyone, and a cancer diagnosis most likely won't make things any easier. And while numerous online dating services have popped up over the last decade, one sticks out above the rest when you're talking cancer. Founded by a cancer survivor in 2007, "C is for Cupid" is one of the first, and few, online dating services designed specifically for people whose lives have been affected by cancer. The service is free, run by a handful of cancer survivors, and aimed at providing a comfortable and fun environment for members to connect with others who can "relate." As of March 2009, there are more than 1,000 members.The Spring 2009 issue of CURE featured an essay--"When Do I Tell Her?"--by cancer survivor Jasan Zimmerman about the complexities and challenges of dating after cancer and when and how much medical history to reveal during the process.C is for Cupid lets members complete at profile for others to view and it is up to them to decide how much personal medical information to reveal. And the private messaging system and mailboxes allow members to pursue relationships--friendship, companionship, or romantic--without sharing detailed information about themselves, such as a personal e-mail address, until they are ready. The site also includes links to other cancer-related websites and organizations.Although dating another cancer survivor may not be for everyone, I think it is a great opportunity and resource for survivors and other people affected by cancer to be able to connect with someone who has "been there" and who may have other similar interests as well.A few other online dating sites for people with cancer include Prescription4Love.com (this one is for people with all types of illnesses, including cancer) and CancerMatch.com.

Related Videos
Image of Dr. Fakih.
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Related Content